Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Lexeo Therapeutics, Inc. Common StockUS flagNASDAQ Global Market
4.50
USD
-0.01
- -
353.35MMarket Cap

Income Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
1
2
1
- -
- -
- -
+ Sales & Services Revenue
1
2
1
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-1
-2
-1
- -
- -
- -
- Operating Expenses
5
52
61
69
106
109
+ Selling, General & Admin
1
7
12
15
32
45
+ Research & Development
4
45
49
53
74
64
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-5
-51
-61
-69
-106
-109
- Non-Operating (Income) Loss
1
- -
-1
-2
-7
-9
+ Interest Expense, Net
- -
- -
-1
-3
-7
-6
+ Interest Expense
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
1
3
8
6
+ Other Non-Op (Income) Loss
- -
- -
- -
1
- -
-3
Pretax Income
-5
-51
-59
-66
-98
-100
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-5
-51
-59
-66
-98
-100
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-5
-51
-59
-66
-98
-100
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-5
-51
-59
-66
-98
-100
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-5
-51
-59
-66
-98
-100
EBIT
-5
-51
-61
-69
-106
-109
EBITDA
-5
-51
-59
-67
-104
-107
EBITDA Margin (%)
-884.86
-3,055.16
-9,077.06
- -
- -
- -
EBITA
-5
-51
-61
-69
-106
-109
Gross Margin (%)
100
100
100
- -
- -
- -
Operating Margin (%)
-884.86
-3,055.94
-9,252.14
- -
- -
- -
Profit Margin (%)
-993.83
-3,055.04
-9,063.76
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
2
2
2
Basic Weighted Avg Shares
25
25
25
5
32
- -
Basic EPS, GAAP
-0.2
-2.01
-2.36
-12.4
-3.09
- -
Basic EPS from Cont Ops
-0.2
-2.01
-2.36
-12.4
-3.09
- -
Diluted Weighted Avg Shares
25
25
25
5
32
- -
Diluted EPS, GAAP
-0.2
-2.01
-2.36
-12.4
-3.09
- -
Diluted EPS from Cont Ops
-0.2
-2.01
-2.36
-12.4
-3.09
- -

Balance Sheet (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
29
137
80
124
126
188
+ Cash, Cash Equivalents & STI
29
136
77
121
122
182
+ Cash & Cash Equivalents
29
136
77
121
35
63
+ ST Investments
- -
- -
- -
- -
87
119
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
3
5
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
17
16
21
80
+ Property, Plant & Equip, Net
- -
- -
14
12
11
9
+ Property, Plant & Equip
- -
- -
14
13
11
10
- Accumulated Depreciation
- -
- -
- -
- -
- -
1
+ LT Investments & Receivables
- -
- -
- -
- -
7
68
+ LT Investments
- -
- -
- -
- -
7
68
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
3
3
3
3
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
3
3
3
3
Total Assets
29
137
97
140
147
269
+ Payables & Accruals
1
6
9
11
16
10
+ Accounts Payable
- -
3
3
4
6
5
+ Accrued Taxes
- -
1
1
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
3
6
7
9
5
+ ST Debt
- -
- -
3
3
3
3
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
3
3
3
3
+ Other ST Liabilities
- -
1
2
3
5
4
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
2
3
5
4
Total Current Liabilities
1
7
14
17
23
17
+ LT Debt
- -
- -
11
9
7
5
+ LT Borrowings
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
11
9
7
5
+ Other LT Liabilities
34
185
185
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
34
185
185
- -
- -
- -
Total Noncurrent Liabilities
34
185
196
9
7
5
Total Liabilities
35
192
210
26
30
22
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
1
2
295
397
627
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
1
2
295
397
627
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-6
-56
-115
-182
-280
-380
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-6
-56
-113
114
117
247
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-6
-56
-113
114
117
247
Total Liabilities & Equity
29
137
97
140
147
269
Shares Outstanding
25
25
25
27
33
73
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
13
12
10
8
Net Debt
-29
-136
-77
-121
-35
-63
Net Debt to Equity
530.54
244.34
68.47
-106.99
-29.97
-25.54
Tangible Common Equity Ratio
-18.83
-40.63
-116.36
81.21
79.52
91.8
Current Ratio
42.15
18.35
5.58
7.21
5.52
11.21
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-5
-51
-59
-66
-98
-100
+ Depreciation & Amortization
- -
- -
1
2
2
2
+ Non-Cash Items
2
- -
2
4
12
9
+ Stock-Based Compensation
- -
- -
2
3
12
12
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
- -
- -
1
- -
-3
+ Chg in Non-Cash Work Cap
- -
6
2
1
3
-10
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
1
-2
-2
+ Inc (Dec) in Accts Payable
- -
7
4
2
6
-6
+ Inc (Dec) in Other
- -
- -
- -
-1
-1
-2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-3
-44
-55
-59
-81
-99
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
100
95
234
+ Increase in Capital Stock
- -
- -
- -
100
95
234
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
-94
-90
+ Dec in LT Investment
- -
- -
- -
- -
- -
106
+ Inc in LT Investment
- -
- -
- -
- -
-94
-195
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-1
- -
-94
-90
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
3
- -
- -
4
- -
-1
+ Cash From Debt
3
- -
- -
4
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
-1
+ Other Financing Activities
30
151
- -
- -
-6
-17
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
32
151
- -
104
89
217
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
29
106
-55
44
-86
28
EBITDA
-5
-51
-59
-67
-104
-107
EBITDA Margin (%)
-884.86
-3,055.16
-9,077.06
- -
- -
- -
Free Cash Flow
-3
-44
-55
-60
-82
-99
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-44
-55
-56
-82
-99
Free Cash Flow per Basic Share
-0.12
-1.76
-2.2
-11.14
-2.57
- -
Price/Free Cash Flow
- -
- -
- -
-1.21
-2.59
- -
Cash Flow to Net Income
0.61
0.87
0.92
0.9
0.83
0.99
Capital Expenditures
- -
- -
-1
- -
- -
- -